Anteris Technologies
MEDICAL DEVICES
Implantable Bioscaffolds
LocationAustralia - Toowong
Open Jobs23
Pipeline
Vascular Post Market ReviewN/A
TAVR with DurAVR® THVN/A
DurAVRTM THV SystemN/A
DurAVR™ THV SystemN/A
R&D Engineering Opportunities
Anteris Technologies
This listing was originally posted on Anteris Technologies's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAnteris® Technologies is a global structural heart company dedicated to revolutionizing cardiac care. With offices in Minneapolis, MN, US; Geneva, Switzerland; and Brisbane and Perth, Australia, we have a growing and inclusive team.
Our mission is to forge new frontiers in cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Transcatheter Aortic Valve Replacement (TAVR) technologies were originally designed for older, high-risk patients. Today, younger, more active patients need a better solution that will not just open and close but restore healthy heart function. We seek to restore healthy blood flow patterns by creating the world’s first biomimetic TAVR valve, DurAVR® THV. This cutting-edge valve, incorporating our proprietary ADAPT® anti-calcification technology, is designed to mimic the natural function of a healthy heart valve.
At Anteris Technologies, our Research & Development teams are focused on advancing innovative structural heart technologies designed to improve patient outcomes and redefine the future of valve therapy. We are building pipelines of engineering talent to support new product development, systems engineering, sustaining engineering, and cross-functional innovation efforts across our growing organization.
We are interested in connecting with engineers who bring experience in:
Successful candidates are technically strong, collaborative, solutions-oriented, and comfortable working within highly regulated environments. Experience supporting Class III medical devices, structural heart technologies, design controls, and FDA or ISO-regulated development processes is highly valued.
This posting may support hiring across various engineering levels. Anticipated base salary ranges are generally as follows:
Join a mission-driven team working to develop breakthrough technologies that have the potential to transform patient care globally.
These evergreen postings are designed to connect us with talented individuals interested in future opportunities at Anteris Technologies. Because openings may vary over time, additional details regarding specific responsibilities, qualifications, work arrangements, and compensation will be shared as candidates move forward in the process for individual roles.
Note: We may require proof of COVID-19 vaccination to comply with health institutions, state, local municipality, and/or travel regulations.
Anteris Technologies recruits, employs, trains, compensates, and promotes regardless of race, religion, color, national origin, sex, disability, age, veteran status, and other protected status as required by applicable law. We have a clear vision: to be a place of belonging for all humans by promoting diversity, multiculturism and inclusion, as a goal and reflection across the organization. Diversity is more than a commitment - it is part of our mission to deliver the best structural heart products on a global scale.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Anteris Technologies?
Help others prepare — share your experience anonymously.
MEDICAL DEVICES
Implantable Bioscaffolds
Upgrade to Pro to access salary benchmarks and market rate data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo